Evidence map›Paper›PMID 37030595›Full record

ArticleMolecular & cellular proteomics : MCP2023

N-Terminomic Changes in Neurons During Excitotoxicity Reveal Proteolytic Events Associated With Synaptic Dysfunctions and Potential Targets for Neuroprotection.

S Sadia Ameen, Nane Griem-Krey, Antoine Dufour, M Iqbal Hossain, Ashfaqul Hoque, Sharelle Sturgeon, Harshal Nandurkar, Dominik F Draxler, Robert L Medcalf, Mohd Aizuddin Kamaruddin and 17 more

Open access · goldAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Degradation of CaMKII is stimulated by its active conformation.The Journal of biological chemistry · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. The GHB analogue HOCPCA improves deficits in cognition and sensorimotor function after MCAO via CaMKIIα.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 12 institutions in 6 countries.

S Sadia AmeenDepartment of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
Nane Griem-KreyDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Antoine DufourDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
M Iqbal HossainDepartment of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia; Department of Pharmacology and Toxicology, University of Alabama, Birmingham, Alabama, USA.
Ashfaqul HoqueSt Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
Sharelle SturgeonAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
Harshal NandurkarAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
Dominik F DraxlerAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
Robert L MedcalfAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
Mohd Aizuddin KamaruddinDepartment of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
Isabelle S LucetChemical Biology Division, The Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
Michael G LeemingBio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
Dazhi LiuDepartment of Neurology, School of Medicine, University of California, Davis, California, USA.
Amardeep DhillonFaculty of Health, Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.
Jet Phey LimFaculty of Health, Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.
Faiza BasheerFaculty of Health, Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.
Hong-Jian ZhuDepartment of Surgery (Royal Melbourne Hospital), University of Melbourne, Parkville, Victoria, Australia.
Laita BokhariDepartment of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
Carli L RoulstonFlorey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
Prasad N ParadkarCSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, East Geelong, Victoria, Australia.
Oded KleifeldFaculty of Biology, Technion-Israel Institute of Technology, Technion City, Haifa, Israel.
Andrew N ClarksonDepartment of Anatomy, Brain Health Research Centre and Brain Research New Zealand, University of Otago, Dunedin, New Zealand.
Petrine WellendorphDepartment of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Giuseppe D CiccotostoDepartment of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: j.ciccotosto@unimelb.edu.au.
Nicholas A WilliamsonBio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: nawill@unimelb.edu.au.
Ching-Seng AngBio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: ching-seng.ang@unimelb.edu.au.
Heung-Chin ChengDepartment of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: heung@unimelb.edu.au.
The University of Melbourne · AUAustralian Centre for HIV and Hepatitis Virology Research · AUDeakin University · AUUniversity of Copenhagen · DKAustralian Centre for Disease Preparedness · AUBrain Research New Zealand · NZFlorey Institute of Neuroscience and Mental Health · AUSt Vincents Institute of Medical Research · AUTechnion – Israel Institute of Technology · ILThe Royal Melbourne Hospital · AUUniversity of Calgary · CAUniversity of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Excitotoxicity, a neuronal death process in neurological disorders such as stroke, is initiated by the overstimulation of ionotropic glutamate receptors. Although dysregulation of proteolytic signaling networks is critical for excitotoxicity, the identity of affected proteins and mechanisms by which they induce neuronal cell death remain unclear. To address this, we used quantitative N-terminomics to identify proteins modified by proteolysis in neurons undergoing excitotoxic cell death. We found that most proteolytically processed proteins in excitotoxic neurons are likely substrates of calpains, including key synaptic regulatory proteins such as CRMP2, doublecortin-like kinase I, Src tyrosine kinase and calmodulin-dependent protein kinase IIβ (CaMKIIβ). Critically, calpain-catalyzed proteolytic processing of these proteins generates stable truncated fragments with altered activities that potentially contribute to neuronal death by perturbing synaptic organization and function. Blocking calpain-mediated proteolysis of one of these proteins, Src, protected against neuronal loss in a rat model of neurotoxicity. Extrapolation of our N-terminomic results led to the discovery that CaMKIIα, an isoform of CaMKIIβ, undergoes differential processing in mouse brains under physiological conditions and during ischemic stroke. In summary, by identifying the neuronal proteins undergoing proteolysis during excitotoxicity, our findings offer new insights into excitotoxic neuronal death mechanisms and reveal potential neuroprotective targets for neurological disorders.

Indexed as

Cell DeathNeuronsSynapsesAnimalsCalpainCells, CulturedCysteine Proteinase InhibitorsDipeptidesIntercellular Signaling Peptides and ProteinsMaleMiceMice, Inbred C57BLNerve Tissue ProteinsNeuroprotectionProteomeRatsCalpaincalpeptincollapsin response mediator protein-2Cysteine Proteinase InhibitorsDipeptidesIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsProteomecalpainsCaM kinase IIaCaM kinase IIbCRMP2excitotoxicityneuronal deathneuroprotectionproteolytic processingSrcsynaptic damage

Identifiers

PMID37030595
PMCPMC10199228
OpenAlexW4362676589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.